KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Shares Outstanding (Weighted Average) (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Shares Outstanding (Weighted Average) for 13 consecutive years, with $56.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 2.45% to $56.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.5 million, a 2.45% increase, with the full-year FY2025 number at $56.5 million, up 2.45% from a year prior.
  • Shares Outstanding (Weighted Average) was $56.5 million for Q4 2025 at Supernus Pharmaceuticals, roughly flat from $56.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $56.6 million in Q3 2025 to a low of $52.9 million in Q1 2021.
  • A 5-year average of $54.4 million and a median of $54.5 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 0.67% in 2024, then grew 2.87% in 2025.
  • Supernus Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $53.1 million in 2021, then increased by 1.07% to $53.7 million in 2022, then rose by 1.62% to $54.5 million in 2023, then rose by 1.03% to $55.1 million in 2024, then grew by 2.45% to $56.5 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Shares Outstanding (Weighted Average) are $56.5 million (Q4 2025), $56.6 million (Q3 2025), and $55.9 million (Q2 2025).